RAC1 and prostate cancer: It has been reported that P-Rex1 is highly expressed in PC3 prostate cancer cells relative to androgen-dependent cell lines, and that silencing P-Rex1 in PC3 prostate cancer cells leads to a reduction in activated Rac1, as well as in the migratory and invasive capacity of these cells [28].